nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—EGF—corneal epithelium—glaucoma	0.128	0.443	CbGeAlD
Sucralfate—EGF—cornea—glaucoma	0.093	0.323	CbGeAlD
Sucralfate—EGF—endothelium—glaucoma	0.0233	0.0811	CbGeAlD
Sucralfate—Venous thrombosis—Carbachol—glaucoma	0.0192	0.142	CcSEcCtD
Sucralfate—Fluid overload—Carbachol—glaucoma	0.0166	0.123	CcSEcCtD
Sucralfate—Extravasation—Carbachol—glaucoma	0.0119	0.0876	CcSEcCtD
Sucralfate—EGF—eye—glaucoma	0.0115	0.0398	CbGeAlD
Sucralfate—EGF—retina—glaucoma	0.0114	0.0394	CbGeAlD
Sucralfate—EGF—connective tissue—glaucoma	0.011	0.0383	CbGeAlD
Sucralfate—FGF2—eye—glaucoma	0.0101	0.0351	CbGeAlD
Sucralfate—Phlebitis—Carbachol—glaucoma	0.00872	0.0644	CcSEcCtD
Sucralfate—Hyponatraemia—Carbachol—glaucoma	0.00754	0.0557	CcSEcCtD
Sucralfate—Hyponatraemia—Acetazolamide—glaucoma	0.00493	0.0364	CcSEcCtD
Sucralfate—Oedema—Metipranolol—glaucoma	0.00415	0.0307	CcSEcCtD
Sucralfate—Oedema—Carteolol—glaucoma	0.00385	0.0284	CcSEcCtD
Sucralfate—Infection—Carbachol—glaucoma	0.00367	0.0271	CcSEcCtD
Sucralfate—Oedema—Latanoprost—glaucoma	0.00337	0.0249	CcSEcCtD
Sucralfate—Body temperature increased—Diclofenamide—glaucoma	0.00299	0.0221	CcSEcCtD
Sucralfate—Body temperature increased—Carbachol—glaucoma	0.00292	0.0216	CcSEcCtD
Sucralfate—Body temperature increased—Methazolamide—glaucoma	0.00275	0.0203	CcSEcCtD
Sucralfate—Oedema—Apraclonidine—glaucoma	0.0027	0.0199	CcSEcCtD
Sucralfate—Infection—Apraclonidine—glaucoma	0.00268	0.0198	CcSEcCtD
Sucralfate—Infection—Bimatoprost—glaucoma	0.0026	0.0192	CcSEcCtD
Sucralfate—Oedema—Brimonidine—glaucoma	0.00231	0.0171	CcSEcCtD
Sucralfate—Infection—Brimonidine—glaucoma	0.0023	0.017	CcSEcCtD
Sucralfate—Oedema—Dorzolamide—glaucoma	0.00221	0.0163	CcSEcCtD
Sucralfate—Oedema—Travoprost—glaucoma	0.0022	0.0163	CcSEcCtD
Sucralfate—Infection—Travoprost—glaucoma	0.00219	0.0161	CcSEcCtD
Sucralfate—Infection—Brinzolamide—glaucoma	0.00216	0.0159	CcSEcCtD
Sucralfate—Oedema—Pilocarpine—glaucoma	0.00209	0.0154	CcSEcCtD
Sucralfate—Infection—Pilocarpine—glaucoma	0.00207	0.0153	CcSEcCtD
Sucralfate—Body temperature increased—Acetazolamide—glaucoma	0.00191	0.0141	CcSEcCtD
Sucralfate—Body temperature increased—Dorzolamide—glaucoma	0.00175	0.0129	CcSEcCtD
Sucralfate—Oedema—Clonidine—glaucoma	0.00167	0.0123	CcSEcCtD
Sucralfate—Infection—Clonidine—glaucoma	0.00166	0.0122	CcSEcCtD
Sucralfate—Body temperature increased—Pilocarpine—glaucoma	0.00165	0.0122	CcSEcCtD
Sucralfate—Oedema—Betaxolol—glaucoma	0.00145	0.0107	CcSEcCtD
Sucralfate—Infection—Betaxolol—glaucoma	0.00144	0.0107	CcSEcCtD
Sucralfate—Body temperature increased—Clonidine—glaucoma	0.00132	0.00974	CcSEcCtD
Sucralfate—Oedema—Timolol—glaucoma	0.00119	0.00876	CcSEcCtD
Sucralfate—Infection—Timolol—glaucoma	0.00118	0.00871	CcSEcCtD
Sucralfate—Body temperature increased—Betaxolol—glaucoma	0.00115	0.00848	CcSEcCtD
Sucralfate—Body temperature increased—Timolol—glaucoma	0.000938	0.00693	CcSEcCtD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000261	0.000453	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—PAX6—glaucoma	0.00026	0.000451	CbGpPWpGaD
Sucralfate—FGF2—Disease—HEYL—glaucoma	0.00026	0.00045	CbGpPWpGaD
Sucralfate—FGF2—Disease—FGFR1OP—glaucoma	0.00026	0.00045	CbGpPWpGaD
Sucralfate—EGF—Disease—HDAC9—glaucoma	0.000256	0.000444	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000253	0.000439	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—NGF—glaucoma	0.00025	0.000434	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TNF—glaucoma	0.000248	0.00043	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP1—glaucoma	0.000244	0.000423	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.000242	0.00042	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—CDKN1B—glaucoma	0.000238	0.000413	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—MMP9—glaucoma	0.000235	0.000407	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.000232	0.000403	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—SMO—glaucoma	0.000229	0.000398	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—MMP1—glaucoma	0.000229	0.000398	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TXNIP—glaucoma	0.000229	0.000397	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—CDKN1B—glaucoma	0.000228	0.000395	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—CDKN1B—glaucoma	0.000227	0.000394	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—CDKN1B—glaucoma	0.000227	0.000393	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—CDKN1B—glaucoma	0.000225	0.000391	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TBK1—glaucoma	0.000225	0.00039	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—SMO—glaucoma	0.000225	0.00039	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—SMO—glaucoma	0.000225	0.00039	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—CDKN1B—glaucoma	0.000224	0.000389	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000224	0.000388	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	0.000223	0.000386	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—FN1—glaucoma	0.000223	0.000386	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	0.000221	0.000383	CbGpPWpGaD
Sucralfate—FGA—Disease—CDKN2B—glaucoma	0.000221	0.000382	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—CAV1—glaucoma	0.00022	0.000381	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TP53—glaucoma	0.000219	0.000379	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—RPTOR—glaucoma	0.000218	0.000377	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—C3—glaucoma	0.000215	0.000372	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—FN1—glaucoma	0.000211	0.000366	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—CDKN1B—glaucoma	0.000211	0.000366	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—CDKN1B—glaucoma	0.000211	0.000366	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	0.000211	0.000366	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NCK2—glaucoma	0.000211	0.000366	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NTRK2—glaucoma	0.00021	0.000364	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00021	0.000364	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—CDKN1B—glaucoma	0.000209	0.000363	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—FN1—glaucoma	0.000209	0.000363	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.000207	0.00036	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—BAD—glaucoma	0.000206	0.000358	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—CDKN1B—glaucoma	0.000206	0.000358	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—C3—glaucoma	0.000206	0.000357	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NTRK2—glaucoma	0.000206	0.000356	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NTRK2—glaucoma	0.000206	0.000356	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—BCL2L1—glaucoma	0.000205	0.000356	CbGpPWpGaD
Sucralfate—FGF2—Immune System—C1QB—glaucoma	0.000203	0.000352	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000201	0.000349	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000199	0.000345	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000199	0.000344	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000197	0.000342	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—VEGFA—glaucoma	0.000196	0.00034	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—OPN4—glaucoma	0.000196	0.000339	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—CDKN1B—glaucoma	0.000195	0.000339	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—VEGFA—glaucoma	0.000192	0.000333	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—VEGFA—glaucoma	0.000192	0.000333	CbGpPWpGaD
Sucralfate—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000191	0.000332	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP2—glaucoma	0.000189	0.000328	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000187	0.000324	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—BAD—glaucoma	0.000186	0.000323	CbGpPWpGaD
Sucralfate—FGA—Disease—MTHFR—glaucoma	0.000185	0.000321	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HEYL—glaucoma	0.000182	0.000315	CbGpPWpGaD
Sucralfate—FGF2—Immune System—TXN—glaucoma	0.000181	0.000314	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NGFR—glaucoma	0.00018	0.000312	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—HDAC9—glaucoma	0.000179	0.000311	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—BAD—glaucoma	0.000179	0.00031	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000178	0.000308	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NGFR—glaucoma	0.000176	0.000306	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NGFR—glaucoma	0.000176	0.000306	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—PTGFR—glaucoma	0.000176	0.000305	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000172	0.000299	CbGpPWpGaD
Sucralfate—FGA—Disease—APOE—glaucoma	0.000172	0.000298	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NTRK1—glaucoma	0.000171	0.000297	CbGpPWpGaD
Sucralfate—FGA—Disease—CAV1—glaucoma	0.000171	0.000296	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NTRK1—glaucoma	0.000168	0.000291	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NTRK1—glaucoma	0.000168	0.000291	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—NOS3—glaucoma	0.000166	0.000288	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000165	0.000286	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CA5A—glaucoma	0.000162	0.000281	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NARFL—glaucoma	0.000162	0.000281	CbGpPWpGaD
Sucralfate—FGF2—Disease—HDAC9—glaucoma	0.000162	0.000281	CbGpPWpGaD
Sucralfate—FGA—Disease—BAD—glaucoma	0.00016	0.000278	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CDKN2B—glaucoma	0.000158	0.000273	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CDKN2B—glaucoma	0.000154	0.000268	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CDKN2B—glaucoma	0.000154	0.000268	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EDN1—glaucoma	0.000151	0.000262	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—glaucoma	0.000148	0.000257	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EDN1—glaucoma	0.000148	0.000257	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EDN1—glaucoma	0.000148	0.000257	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—glaucoma	0.000148	0.000257	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—glaucoma	0.000145	0.000251	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—glaucoma	0.000145	0.000251	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—CDKN1B—glaucoma	0.000144	0.000249	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL1A—glaucoma	0.000142	0.000247	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	0.000142	0.000246	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP9—glaucoma	0.000142	0.000246	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000142	0.000245	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—SMO—glaucoma	0.00014	0.000243	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NGF—glaucoma	0.000139	0.000241	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—RPTOR—glaucoma	0.000138	0.000239	CbGpPWpGaD
Sucralfate—EGF—Disease—CDKN2B—glaucoma	0.000138	0.000239	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NGF—glaucoma	0.000136	0.000236	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NGF—glaucoma	0.000136	0.000236	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—C3—glaucoma	0.000136	0.000235	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000135	0.000233	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NCK2—glaucoma	0.000133	0.000231	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000133	0.00023	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—C3—glaucoma	0.000132	0.000229	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—C3—glaucoma	0.00013	0.000226	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—BCL2L1—glaucoma	0.00013	0.000225	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CDKN1B—glaucoma	0.00013	0.000225	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—C3—glaucoma	0.000129	0.000224	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—C3—glaucoma	0.000129	0.000224	CbGpPWpGaD
Sucralfate—FGA—Disease—NOS3—glaucoma	0.000129	0.000224	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NTRK2—glaucoma	0.000128	0.000222	CbGpPWpGaD
Sucralfate—EGF—Immune System—C3—glaucoma	0.000125	0.000217	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000125	0.000216	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CDKN1B—glaucoma	0.000124	0.000216	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—APOE—glaucoma	0.000123	0.000213	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CAV1—glaucoma	0.000122	0.000211	CbGpPWpGaD
Sucralfate—ALB—Platelet degranulation—VEGFA—glaucoma	0.000121	0.00021	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—glaucoma	0.000121	0.000209	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—APOE—glaucoma	0.000121	0.000209	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—APOE—glaucoma	0.000121	0.000209	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—VEGFA—glaucoma	0.00012	0.000208	CbGpPWpGaD
Sucralfate—EGF—Immune System—BCL2L1—glaucoma	0.00012	0.000207	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CAV1—glaucoma	0.000119	0.000207	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CAV1—glaucoma	0.000119	0.000207	CbGpPWpGaD
Sucralfate—FGA—Disease—PTGS2—glaucoma	0.000118	0.000204	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—BAD—glaucoma	0.000118	0.000204	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—FN1—glaucoma	0.000116	0.000201	CbGpPWpGaD
Sucralfate—EGF—Disease—MTHFR—glaucoma	0.000115	0.0002	CbGpPWpGaD
Sucralfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.000115	0.0002	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—BAD—glaucoma	0.000115	0.000199	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MMP2—glaucoma	0.000114	0.000198	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—FN1—glaucoma	0.000114	0.000197	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—FN1—glaucoma	0.000114	0.000197	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—HDAC9—glaucoma	0.000113	0.000197	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—BAD—glaucoma	0.000113	0.000196	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—BAD—glaucoma	0.000112	0.000195	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—BAD—glaucoma	0.000112	0.000195	CbGpPWpGaD
Sucralfate—FGA—Disease—CDKN1B—glaucoma	0.000112	0.000194	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NGFR—glaucoma	0.00011	0.000191	CbGpPWpGaD
Sucralfate—EGF—Immune System—BAD—glaucoma	0.000108	0.000188	CbGpPWpGaD
Sucralfate—EGF—Disease—APOE—glaucoma	0.000107	0.000186	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—glaucoma	0.000106	0.000185	CbGpPWpGaD
Sucralfate—EGF—Disease—CAV1—glaucoma	0.000106	0.000185	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NTRK1—glaucoma	0.000105	0.000181	CbGpPWpGaD
Sucralfate—EGF—Disease—BAD—glaucoma	0.0001	0.000174	CbGpPWpGaD
Sucralfate—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.72e-05	0.000169	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDKN2B—glaucoma	9.64e-05	0.000167	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—glaucoma	9.6e-05	0.000166	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	9.37e-05	0.000162	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EDN1—glaucoma	9.25e-05	0.00016	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—NOS3—glaucoma	9.22e-05	0.00016	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TGFB2—glaucoma	9.15e-05	0.000159	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—glaucoma	9.05e-05	0.000157	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—NOS3—glaucoma	9.03e-05	0.000157	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—NOS3—glaucoma	9.03e-05	0.000157	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL1A—glaucoma	9e-05	0.000156	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—SMO—glaucoma	8.88e-05	0.000154	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDKN2B—glaucoma	8.71e-05	0.000151	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—MMP9—glaucoma	8.6e-05	0.000149	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NGF—glaucoma	8.5e-05	0.000147	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CDKN1B—glaucoma	8.2e-05	0.000142	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NTRK2—glaucoma	8.12e-05	0.000141	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—C3—glaucoma	8.08e-05	0.00014	CbGpPWpGaD
Sucralfate—EGF—Disease—NOS3—glaucoma	8.05e-05	0.00014	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CDKN1B—glaucoma	7.98e-05	0.000138	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CA1—glaucoma	7.93e-05	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Immune System—C3—glaucoma	7.91e-05	0.000137	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDKN1B—glaucoma	7.88e-05	0.000137	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CDKN1B—glaucoma	7.82e-05	0.000136	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CDKN1B—glaucoma	7.82e-05	0.000136	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—VEGFA—glaucoma	7.72e-05	0.000134	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CTSA—glaucoma	7.68e-05	0.000133	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BCL2L1—glaucoma	7.57e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDKN1B—glaucoma	7.55e-05	0.000131	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—APOE—glaucoma	7.52e-05	0.00013	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CAV1—glaucoma	7.45e-05	0.000129	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—MMP9—glaucoma	7.39e-05	0.000128	CbGpPWpGaD
Sucralfate—EGF—Disease—PTGS2—glaucoma	7.36e-05	0.000128	CbGpPWpGaD
Sucralfate—FGF2—Disease—MTHFR—glaucoma	7.3e-05	0.000127	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CA2—glaucoma	7.25e-05	0.000126	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—MMP9—glaucoma	7.24e-05	0.000126	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—MMP9—glaucoma	7.24e-05	0.000126	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—FN1—glaucoma	7.09e-05	0.000123	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.09e-05	0.000123	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.09e-05	0.000123	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—BAD—glaucoma	7.01e-05	0.000122	CbGpPWpGaD
Sucralfate—EGF—Disease—CDKN1B—glaucoma	6.97e-05	0.000121	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NGFR—glaucoma	6.97e-05	0.000121	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—SOD1—glaucoma	6.94e-05	0.00012	CbGpPWpGaD
Sucralfate—FGF2—Immune System—BAD—glaucoma	6.86e-05	0.000119	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOE—glaucoma	6.8e-05	0.000118	CbGpPWpGaD
Sucralfate—FGF2—Disease—CAV1—glaucoma	6.73e-05	0.000117	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—VEGFA—glaucoma	6.64e-05	0.000115	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—glaucoma	6.62e-05	0.000115	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NTRK1—glaucoma	6.62e-05	0.000115	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—VEGFA—glaucoma	6.5e-05	0.000113	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—VEGFA—glaucoma	6.5e-05	0.000113	CbGpPWpGaD
Sucralfate—FGF2—Disease—BAD—glaucoma	6.33e-05	0.00011	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDKN2B—glaucoma	6.1e-05	0.000106	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EDN1—glaucoma	5.85e-05	0.000101	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—NOS3—glaucoma	5.63e-05	9.77e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NGF—glaucoma	5.38e-05	9.32e-05	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	5.36e-05	9.29e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—MMP1—glaucoma	5.29e-05	9.17e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—C3—glaucoma	5.11e-05	8.86e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TXN—glaucoma	5.11e-05	8.86e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—NOS3—glaucoma	5.09e-05	8.83e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CAV1—glaucoma	5.07e-05	8.79e-05	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—glaucoma	5.02e-05	8.7e-05	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—glaucoma	4.91e-05	8.52e-05	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—glaucoma	4.91e-05	8.52e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CDKN1B—glaucoma	4.88e-05	8.46e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—FN1—glaucoma	4.83e-05	8.37e-05	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDKN1B—glaucoma	4.78e-05	8.28e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—APOE—glaucoma	4.76e-05	8.25e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CAV1—glaucoma	4.72e-05	8.18e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.66e-05	8.08e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—PTGS2—glaucoma	4.66e-05	8.08e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.62e-05	8.01e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—MMP9—glaucoma	4.52e-05	7.84e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—FN1—glaucoma	4.49e-05	7.78e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—BAD—glaucoma	4.44e-05	7.69e-05	CbGpPWpGaD
Sucralfate—FGF2—Disease—CDKN1B—glaucoma	4.41e-05	7.65e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—VEGFA—glaucoma	4.06e-05	7.04e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTT1—glaucoma	3.96e-05	6.87e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—NOS3—glaucoma	3.84e-05	6.65e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—NOS3—glaucoma	3.57e-05	6.18e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.19e-05	5.54e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ABCA1—glaucoma	3.16e-05	5.47e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CYP1B1—glaucoma	3.16e-05	5.47e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CDKN1B—glaucoma	3.09e-05	5.36e-05	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—glaucoma	3.07e-05	5.32e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—MMP9—glaucoma	2.86e-05	4.96e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—VEGFA—glaucoma	2.76e-05	4.79e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—VEGFA—glaucoma	2.57e-05	4.45e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—GSTM1—glaucoma	2.52e-05	4.37e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—MTHFR—glaucoma	2.23e-05	3.87e-05	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—glaucoma	2.09e-05	3.62e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—APOE—glaucoma	2.08e-05	3.6e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CAV1—glaucoma	2.06e-05	3.57e-05	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—glaucoma	1.94e-05	3.37e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—NOS3—glaucoma	1.55e-05	2.7e-05	CbGpPWpGaD
Sucralfate—ALB—Metabolism—PTGS2—glaucoma	1.42e-05	2.47e-05	CbGpPWpGaD
